Immune Reactive Conditions: The mercury connection to eczema, psoriasis, lupus, asthma, scleroderma, rheumatoid arthritis, and

Immune Reactive Conditions: The mercury connection to eczema, psoriasis, lupus, asthma, scleroderma, rheumatoid arthritis, and allergies (snipped from larger study)

Bernard Windham(Ed.)

I. Introduction.

This paper documents that a significant percentage of people are allergic or immune reactive to mercury to varying degrees, and that millions are adversely affected by such conditions, including many disabled by related autoimmune conditions. The incidence of allergic and immune reactive conditions such as allergies, asthma, eczema, lupus, psoriasis, MS, etc. have been increasing rapidly in recent years (1-3,21,23).

Autism incidence rate had a 10 fold increase in the last decade and ADHD had major increases likewise(16,116). At least 50 million have allergies(19%)(1d) and according to the U.S. CDC(1c) approximately 20 million have asthma(7.7%). The largest increase has been in infants (1,2,6,7,21,23,16), and approximately 10 % of infants- approximately 15 million in the U.S. with systemic eczema(1ab,9,16). Studies researching the reason for these rapid increases in infant reactive conditions seem to implicate earlier and higher usage of vaccines containing mercury (thimerasol) as a likely connection (2,6,21,23,16), plus fetal and neonatal exposure from mother’s blood and milk (115). It has been estimated that by age 3 the typical child has received over 235 micrograms of mercury thimerasol from vaccinations which is considerably more than Federal mercury safety guidelines, in addition to significant levels of mercury exposure from other sources for many(2,21,23,16). Infants during this period have undeveloped immune systems and blood brain barriers, and much of the mercury goes to the brain, resulting in significant adverse neurological effects in those that are most susceptible. Many thousands of parents have reported that their child got such conditions after vaccination, and tests have confirmed high levels of mercury in many of those tested, along with other toxic exposures. Many of those diagnosed with high mercury levels have also been found to have significant improvement after mercury detoxification (16,23,11,12,etc.). Thimerasol had been previously removed from similar preservative uses in eye drops and eye medications after evidence of a connection to chronic degenerative eye conditions. After over 15,000 law suits were filed in France over adverse effects of the Hepatitis B vaccine, the French Minister of Health ended the mandatory hepatitis B vaccination program for all school children. Adverse effects included neurological disorders and autoimmune disorders such as multiple sclerosis and lupus.

People with chronic and immune reactive problems are increasingly finding dental materials are a factor in their problems and getting biocompatibility tests run to test their immune reactivity to the various dental materials used. A high percentage of such patients test immune reactive to mercury and some of the other toxic metals. Of the many thousands who have had the Clifford immune reactivity test and the similar Peak Lab test, over 90% tested immune reactive to mercury and often to other metals as well(46). The extreme immunotoxicity of mercury and resulting damage to immune system cells and the immune system by mercury exposure is likely a factor in this. MELISA is an immune reactivity test developed to measure “significant” immune reactivity to substances to the degree that often results in autoimmune reactions and autoimmune conditions like CFS, Fibromyalgia, oral lichen planus, MS, rheumatoid arthritis, lupus, etc. Of a population of over 3000 with chronic health problems tested by the immune lymphocyte reactivity test(MELISA,12a), 20% tested positive for inorganic mercury, 13% for phenyl mercury, 8% for methyl mercury, and 7% for mercury thimerasol. For people with autoimmune conditions such as CFS, Fibromyalgia, or Multiple Chemical Sensitivity, the percentage testing immune reactive to mercury was much higher- 28% percent were immune reactive to palladium, 26% to gold, 23% to inorganic mercury, 23% to phenyl mercury, and 12% to methyl mercury, as compared to less than 5% for controls. Of 98 patients who had amalgam fillings replaced, 76% had long term health improvement and significant improvement in MELISA scores.

II. Allergic health effects related to mercury exposure.

Many studies including hundreds of thousands of clinical cases as well as Scientific Panels have found that the number one source of mercury in adults is mercury amalgam fillings and exposures to those with amalgam commonly exceed government health guidelines for mercury (199,134). Amalgam has also been found to be the largest source of methyl mercury in most who have amalgam fillings (134,199). Amalgam fillings of mothers is also a significant source of exposure to infants as mercury in the mother crosses the placenta in levels higher than in the mother and significant exposure also occurs through breast milk(115).

Studies have found mercury to be a major factor in allergic/immune reactive conditions including lupus(27-32,46d,47,88), contact dermatitis (3-10,91),eczema (3-9,18-20, 34,31), psoriasis(33-38,54,31, 11) , oral lichen planus (11,39-42), systemic eczematous contact-type dermatitis (baboon syndrome)(7), stomatitis(10b,54), scleroderma(47,87), allergies(11-15,31,43-49), asthma (47-51,65,16), and rheumatoid arthritis(47,49,88). Mercury has been shown to be a factor that can cause rheumatoid arthritis by activating localized CD4+ T-cells which trigger production of immune macrophages and immunoglobulin(Ig) producing cells in joints(12,513,514).

Allergic contact eczema is the most frequent occupational disease(1,91), occurring in over 10% of children in some areas; and the most common cause of contact eczema is exposure to toxic metals(1, 5-9). The metals most commonly causing allergic immune reactivity are nickel, mercury, chromium, cobalt, and palladium(5-15,60,91,200). Nickel in stainless steel braces and crowns is a source of reactivity and autoimmunity along with gold and palladium in crowns(32bc,11,12) The highest level of sensitization is to Infants, who are most reactive to thimerosal, a form of mercury that has been used as a preservative in vaccines and eye drops(6,5b,16). There is strong suggestive and clinical evidence for a connection between toxic metals and autism (16,21,2,23-25,81,86). Although nickel has historically been the number one source of metal allergy and contact allergy, with many dozens of medical studies documenting the connection to conditions such as contact eczema, in recent years the largest increase in infant reactivity appears to be related to mercury exposure(6,7, 32,86,16). Also mercury has been found to be the most significant factor in large numbers of reactive autoimmune allergic and neurological conditions(11-15,201) Thus in assessing mechanisms by which these conditions are related to metals, this paper will focus more on mercury. Some of this would be similar for other metals however.

Mercury causes release of inflammatory cytokines such as Tumor Necrosis Factor-alpha(TNFa) and Interleukin-4 which are documented to be factors in the chronic inflammatory conditions discussed here, including asthma, lupus, rheumatoid arthritis, scleroderma, celiac and chron’s disease, etc. (47,49,65,87-92) and also is involved in chronic heart problems.

TNFa(tumor necrosis factor-alpha) is a cytokine that controls a wide range of immune cell response in mammals, including cell death(apoptosis). This process is involved in inflammatory and degenerative neurological conditions like ALS, MS, Parkinson’s, rheumatoid arthritis, etc. Cell signaling mechanisms like sphingolipids are part of the control mechanism for the TNFa apoptosis mechanism(101a). Gluthathione is an amino acid that is a normal cellular mechanism for controlling apoptosis. When glutathione is depleted in the brain, reactive oxidative species increased, and CNS and cell signaling mechanisms are disrupted by toxic exposures such as mercury, neuronal cell apoptosis results and neurological damage. Mercury has been shown to induce TNFa, deplete glutathione, and increase glutamate, dopamine, and calcium related toxicity, causing inflammatory effects and cellular apoptosis in neuronal and immune cells(101b,101c).

Na(+),K(+)-ATPase is a transmembrane protein that transports sodium and potassium ions across cell membranes during an activity cycle that uses the energy released by ATP hydrolysis. Mercury is documented to inhibit Na(+),K(+)-ATPase function at very low levels of exposure(94). Studies have found that in asthma, lupus, rheumatoid arthritis, scleroderma, celiac/chron’s/IBS, and eczema cases there was a reduction in serum magnesium and RBC membrane Na(+)-K+ ATPase activity and an elevation in plasma serum digoxin (87-90,65). The activity of some free-radical scavenging enzymes, concentration of glutathione decreased significantly, while the concentration of serum lipid peroxidation products and nitric oxide increased. The inhibition of Na+-K+ ATPase can contribute to increase in intracellular calcium and decrease in magnesium, which can result in 1) defective neurotransmitter transport mechanism, 2) neuronal degeneration and apoptosis, 3) mitochondrial dysfunction, 4) defective golgi body function and protein processing dysfunction. It is documented that mercury is a cause of most of these conditions (30,29,65,87-90,95,96,etc.)

Dental staff have been found to have significantly higher prevalence of eye problems, conjunctivitis, atopic dermatitis, and contact urticaria(91c). Finnish dental staff have the highest occupational risk of contact dermatitis with 71% affected over time(91b) with plastics, rubber, and mercury the most common causes of sensitization. Korean dental technicians have a high incidence of contact dermatitis, with dental metals the most common sensitizers. Over 25% had contact dermatitis with over 10% sensitive to 5 metals, chromium, mercury, nickel, cobalt, and palladium(91a). 16.3% were immune reactive to mercury.

One mechanism of mercury’s affect on contact sensitivities is the inhibition of glutathione S- transferase(92), which is a modulator of inflammation. Mercury also causes intestinal damage and leaky gut, causing metabolic damage and increasing food sensitivities(93).

A direct mechanism involving mercury’s inhibition of cellular enzymatic processes by binding with the hydroxyl radical(SH) in amino acids appears to be a major part of the connection to these allergic/immune reactive conditions(13,15,16,23-31,56-58). For example mercury has been found to strongly inhibit the activity of dipeptyl peptidase (DPP IV) which is required in the digestion of the milk protein casein(25,26,16). Studies involving a large sample of autistic and schizophrenic patients found that over 90 % of those tested had high levels of the milk protein beta-casamorphin-7 in their blood and urine and defective enzymatic processes for digesting milk protein(24). Casamorphin is a morphine like compound that results in neural disfunction. Elimination of milk products from the diet has been found to improve the condition. As noted previously, such populations have also been found to have high levels of mercury and to recover after mercury detox(23,11,12,16). As mercury levels are reduced the protein binding is reduced and improvement in the enzymatic process occurs(16,200). Additional cellular level enzymatic effects of mercury’s binding with proteins include blockage of sulfur oxidation processes, enzymatic processes involving vitamins B6 and B12, effects on the cytochrome-C energy processes, along with mercury’s adverse effects on cellular mineral levels of calcium, magnesium, zinc, and lithium(16,200). And along with these blockages of cellular enzymatic processes, mercury has been found to cause additional neurological and immune system effects in many through immune/autoimmune reactions(11-15,201). But the effect on the immune system of exposure to various toxic substances such as toxic metals and environmental pollutants has also been found to have additive or synergistic effects and to be a factor in increasing eczema, allergies, asthma, and sensitivity to other lesser allergens. Many of the immune reactive children tested for toxic exposures have found high or reactive levels of other toxic metals, and organochlorine compounds(11,12,4). Other than the organochlorines or toxic metals which are discussed later, four common pollutants that have been documented to have effects on such conditions are traffic and industrial pollutants nitrogen oxide, sulfur dioxide, power plant residual oil fly ash, and organochlorine pollutants(4).

Mercury vapor exposure at very low levels adversely affects the

immune system (11-15, 44-46, 56-62). From animal studies it has been

determined that mercury damages T-cells by generating reactive oxygen

species(ROS), depleting the thiol reserves of cells, damaging and

decreasing the dimension of mitochondria, causing destruction of

cytoplasmic organelles with loss of cell membrane integrity, inhibiting

ability to secrete interleukin IL-1 and IL-2R, causing activation of glial cells

to produce superoxide and nitric oxide, and inactivating or inhibiting

enzyme systems involving the sulphydryl protein groups(13-6,45,57,200).

Mercury caused adverse effects on both neutrophil and macrophage

function and after depletion of thiol reserves, T-cells were susceptible to

Hg induced cellular death (apoptosis)(15,63,64). Interferon syntheses

was reduced in a concentration dependent manner with either mercury or

methyl mercury as well as other immune functions(13-15,200), and low

doses also induce aggregation of cell surface proteins and dramatic

tyrosine phosporlation of cellular proteins related to asthma(49-51) and

allergic diseases such as eczema and lupus(27-38,201), and

autoimmunity(11-15,56-58). One study found that insertion of amalgam

fillings or nickel dental materials causes a suppression of the number of T-

lymphocytes(60), and impairs the T-4/T-8 ratio. Low T4/T8 ratio has been

found to be a factor in lupus, anemia, MS, eczema, inflammatory bowel

disease, and glomerulonephritis. Mercury induced autoimmunity in

animals and humans has been found to be associated with mercury’s

expression of major histocompatibility complex(MHC) class II genes

(56,14,15,57c). Both mercuric and methyl mercury chlorides caused dose

dependent reduction in immune B-cell production (59). B-cell expression

of IgE receptors were significantly reduced(59), with a rapid and sustained

elevation in intracellular levels of calcium induced(59,65). Antigen specific

LST-test was performed on a large number of patients with atopic

eczema(33), using T-cells of peripheral blood. 87% showed LST positive

reactions to Hg, 87% to Ni, 38% to Au and 40% to Pd They removed LST

positive dental metals from the oral cavities of patients. Improvement of

symptoms was obtained in 82% (160/196) of the patients within 1-10

months. Similar results have been obtained at other clinics(11,34-38).

Mercury and toxic substances effects on suppressing the immune system also are documented to cause increased susceptibility to other pathogens such as viruses, mycoplasma, bacterial infections, and parasites. The majority of those with autoimmune conditions like ALS, CFS, FMS, MS have been found to also be infected with mycoplasma and other pathogens(98-100).

Many studies have found that the body’s basic building blocks, amino acids with SH hydroxyl radicals form strong bonds with the toxic metals such as mercury, resulting in compounds which the immune system recognizes as “foreign” or non-functional in the basic digestive enzymatic processes that use them as fuel and building blocks in cell structure. This results in activation of the immune system, and when there is a chronic exposure can lead to an autoimmune process that results in significant symptoms and various autoimmune diseases and conditions such as these systemic allergic conditions as well as others such as chronic fatigue(CFS), multiple chemical sensitivities(MCS), and fibromyalgia(11-15,201).

As previously noted, many occupational and children’s studies have found mercury and other toxic metals to be a common cause of immune reactivity and contact and systemic skin conditions including eczema(4-12,31-38). One of the confusions about mercury is that there are several forms of mercury, with different mechanisms of exposure for the different forms, as well as different mechanisms in which the forms of mercury affect the body and immune system. However all have been documented to be extremely neurotoxic and immunotoxic, and to cause autoimmunity in susceptible individuals. Many studies including patch tests and immune reactivity tests have been carried out to assess the level of mercury sensitivity in different populations. They have found that there is a significant portion of the population that are reactive and sensitive to mercury and such have significant effects. In a group of medical students tested by patch test, 12.8 % were sensitive to mercury(17). The mercury sensitized students were found to have more than average number of amalgam fillings, higher urine mercury than non-sensitized students, and more allergic reactions to other things such as cosmetics, soaps, shampoos, etc. Many other studies have found similar levels of sensitization in recent years, with those populations with higher exposures such as those with many fillings or dental staff tending to have higher levels of sensitization(11,12,200) and more adverse health effects. In a group of 8 with contact eczema patch tested for mercury in Spain, all were positive for mercurochrome, six to inorganic mercury, and some to thimerosal(18). This study like several others noted the danger in patch tests for mercury as 2 of the patients suffered anaphylactic shock after the patch test due to the extreme immune reactivity of some to mercury.

Inorganic mercury was found to be a cause of systemic eczema and digestive problems by a Japanese study(19). There is consensus among researchers and dental authorities that amalgam fillings is the main cause of oral lichen planus and the condition is usually cured by amalgam removal(39-42,54).

Mercury blocks the immune function of magnesium and zinc (125-128), whose deficiencies are known to cause significant neurological effects(129-131). The low Zn levels result in deficient CuZnSuperoxide dismustase (CuZnSOD), which in turn leads to increased levels of superoxide due to toxic metal exposure.

III. Autoimmunity caused by Mercury: Connection to Immune and Neurological Conditions

Mercury has been documented to cause autoimmune disease (139,140,118,60,82,141,11,12) and many researchers have concluded that autoimmunity is a factor in the major chronic neurological diseases such as MS, ALS, PD, SLE, RA, etc. Mercury and other toxic metals also form inorganic compounds with OH, NH2, CL, in addition to the SH radical and thus inhibits many cellular enzyme processes, coenzymes, hormones, and blood cells(12b,200). Mercury has been found to impair conversion of thyroid T4 hormone to the active T3 form as well as causing autoimmune thyroiditis common to such patients(142,12). In general, immune activation from toxic metals such as mercury resulting in cytokine release and abnormalities of the hypothalamus‑pituitary‑adrenal(HPA) axis can cause changes in the brain, fatigue, and severe psychological symptoms (12,143,144-147,12b,118) such as profound fatigue, muscosketal pain, sleep disturbances, gastrointestinal and neurological problems as are seen in CFS, fibromyalgia, and autoimmune thyroidititis. Such hypersensitivity has been found most common in those with genetic predisposition to heavy metal sensitivity(11,12,142), such as found more frequently in patients with human lymphocyte antigens (HLA‑DRA) (142,146,147,12). A significant portions of the population appear to fall in this category.

The enzymatic processes blocked by such toxic substances as

mercury also result in chronic formation of metal‑protein compounds (HLA

antigens or antigen-presenting macrophages) that the body’s immune

system(T-lymphocytes) does not recognize, resulting in autoimmune

reactions (103,12a,12b). The metals bind to SH-groups on proteins which

can then be recognized as “foreign” and attacked by immune lymphocytes

Such has been extensively documented by studies such as the

documentation of the autoimmune function test MELISA, a sophisticated

immune/autoimmune test which was developed to test for such

reactions(11,12b).

Very low doses and short term exposures of inorganic Hg (20-200 mug/kg) exacerbates lupus and accelerates mortality in mice. Low dose Hg exposure increases the severity and prevalence of experimental autoimmune myocarditis induced by other factors. In a study of small-scale gold mining using mercury, there was a positive interaction between Hg autoimmunity and malaria. These results suggest a new model for Hg immunotoxicity, as a co-factor in autoimmune disease, increasing the risks and severity of clinical disease in the presence of other triggering events, either genetic or acquired(28e).

Autoimmune reactions to inorganic and methyl mercury have been found to be relatively independent, occurring in over 10% of controls. Among a population of patients being tested for autoimmune problems, 94% of such patients had significant immune reactions to inorganic mercury(MELISA test,11,12a,12b) and 72% had immune reactions to low concentrations of HgCl2(<0.5 ug/ml). Of a population of 86 patients with CFS symptoms who had amalgam fillings replaced, 78% reported significant health improvement in a relatively short time period after replacement, and MELISA test scores had a significant reduction in lymphocyte reactivity compared to pre- replacement(12). The MELISA test has proved successful in diagnosing and treating environmentally caused autoimmune diseases such as MS, SLE, oral lichen planus, CFS,etc. (11,12,148). A high percentage of patients subjectively diagnosed with CNS and systemic symptoms suggestive of mercury intoxication have been found to have immune reactivity to inorganic mercury(MELISA test,148), and likewise for MRI positive patients for brain damage. Controls without CNS problems did not have such positive correlations. Nickel, palladium, and gold have also been found to induce autoimmunity in genetically predisposed or highly exposed individuals (11,12,13,149). Tests have found a significant portion of people(over 10%) to be in this category and thus more affected by exposure to amalgam than others. Once compromised by a toxic substance that depletes the immune protectors and causes autoimmunity, the immune system is more susceptible to being sensitized to other toxic chemicals, a factor in multiple chemical sensitivity(MCS). Mercury also causes a reduction in thyroid production(150) and an accumulation in the thyroid of radiation. Among those with chronic immune system problems with related immune antibodies, the types showing the highest level of antibody reductions after amalgam removal include glomerular basal membrane, thyroglobulin, and microsomal thyroid antigens(140,142,12).

Toxic metals appear to be only one of the factors involved in chronic autoimmune conditions and appear to often be cofactors with other triggering effects(28e). Very low doses and short term exposures of inorganic Hg (20-200 mug/kg) exacerbates lupus and accelerates mortality in mice. Low dose Hg exposure increases the severity and prevalence of experimental autoimmune myocarditis induced by other factors. In a study of small-scale gold mining using mercury, there was a positive interaction between Hg autoimmunity and malaria. These results suggest a new model for Hg immunotoxicity, as a co-factor in autoimmune disease, increasing the risks and severity of clinical disease in the presence of other triggering events, either genetic or acquired(28e). Pathogens such as viruses, mycoplasma, bacteria and parasites have been found to usually be present and a factor to deal with in treating those with chronic degenerative conditions and weakened immune systems such as MS(97e,98 ,99,100) and other autoimmune conditions.

Mercury’s biochemical damage at the cellular level include DNA damage, inhibition of DNA and RNA synthesis (102-105); induction of free radical formation (12,95), depletion of cellular glutathione (necessary for detoxification processes) (30de,106,101), inhibition of glutathione peroxidase enzyme(95), inhibition of glutamate uptake(108), induces peroxynitrite and lipid peroxidation damage(109), inducement of inflammatory cytokines(101,111,14), causes abnormal immune system damage (15,63,69,107,110); and autoimmunity (12-15,63,112,etc.)

Metals like mercury bind to SH-groups(sulphydryl) in sulfur compounds like amino acids and proteins, changing the structure of the compound that it is attached to. This often results in the immune systems T-cells not recognizing them as appropriate nutrients and attacking them(13-15,112). Such binding and autoimmune damage has been documented in the fat-rich proteins of the myelin sheaths and of collagen(12b), which are affected in MS. Metals by binding to SH radicals in proteins and other such groups can cause autoimmunity by modifying proteins which via T-cells activate B-cells that target the altered proteins inducing autoimmunity as well as causing aberrant MHC II expression on altered target cells(115de,117). Studies have also found mercury and lead cause autoantibodies to neuronal proteins, neurofilaments, and myelin basic protein(MBP) (118ag,12,119,120,121). Mercury and cadmium also have been found to interfere with zinc binding to MBP(122b) which affects MS symptoms since zinc stabilizes the association of MBP with brain myelin(122a). MS has also been found to commonly be related to inflammatory activity in the CNS such as that caused by the reactive oxygen species and cytokine generation caused by mercury and other toxic metals (12,119,120,121). Antioxidants like lipoic acid which counteract such free radical activity have been found to alleviate symptoms and decrease demyelization(123,124). A group of metal exposed MS patients with amalgam fillings were found to have lower levels of red blood cells, hemoglobin, hemocrit, thyroxine, T-cells, and CD8+ suppressor immune cells than a group of MS patients with amalgam replaced, and more exacerbations of MS than those without(80). Immune and autoimmune mechanisms are thus seen to be a major factor in neurotoxicity of metals.

Autoimmunity has also been found to be a factor in chronic degenerative autoimmune conditions such as MS,ALS, etc., with genetic susceptibility a major factor in who is affected. One genetic factor in Hg induced autoimmunity is major histocompatibility complex(MHC) linked. Both immune cell type Th1 and Th2 cytokine responses are involved in autoimmunity(57c). One genetic difference found in animals and humans is cellular retention differences for metals related to the ability to excrete mercury(58). For example it has been found that individuals with genetic blood factor type APOE-4 do not excrete mercury readily and bioaccumulate mercury, resulting in susceptibility to chronic autoimmune conditions such as Alzheimer’s, Parkinson’s, etc. as early as age 40(132), whereas those with type APOE-2 readily excrete mercury and are less susceptible (132). Those with type APOE-3 are intermediate to the other 2 types. The incidence of autoimmune conditions has increased to the extent this is now one of the leading causes of death among women(135). Also when a condition has been initiated and exposure levels decline, autoimmune antibodies also decline in animals or humans (136,28c,11,118,137,12)

Exposure to mercury results in metalloprotein compounds that have

genetic effects, having both structural and catalytic effects on gene

expression(114). Some of the processes affected by such metalloprotein

control of genes include cellular respiration, metabolism, enzymatic

processes, metal-specific homeostasis, and adrenal stress response

systems.

Significant physiological changes occur when metal ion concentrations

exceed threshold levels. Such metalloprotein formation also appears to

cause a change in antigenicity and autoimmune reactions in significant

numbers of people(103,11,12a,12b). Much mercury in saliva

and the brain is also organic, the most neurotoxic form(138,63), since

mouth bacteria and other organisms in the body methylate inorganic

mercury to organic mercury(134,133). Dental amalgam has been found to

be the largest source of methyl mercury in most with mercury amalgam

fillings(134,199,etc.).

IV. Recovery from Chronic Immune and Neurological Related Diseases After Amalgam Removal and Mercury Detoxification

Much of the direct chronic exposure to toxic metals for persons with the autoimmune diseases discussed here appears to be from use of metals in dental work. The most common dental metals that have been documented to be causing widespread adverse health effects are mercury, nickel, palladium, gold, and copper. Although chronic exposure clearly is affecting a much larger population, nickel has been found to be a major factor in many cases of MS and lupus, with palladium having very similar effects to nickel.

Many clinics and studies involving thousands of patients have found that patients with allergic reactive conditions such as oral lichen planus, eczema, chronic allergies etc. usually recover or have significant improvements after amalgam replacement. Of a group of 86 patients with CFS symptoms, 78% reported significant health improvements after replacement of amalgam fillings within a relatively short period, and MELISA test found significant reduction in lymphocyte reactivity compared to pre removal tests(11,12). The improvement in symptoms and lymphocyte reactivity imply that most of the Hg-induced lymphocyte reactivity is allergenic in nature. Patients with other systemic neurological or immune symptoms such as arthritis, myalgia, CFS, MCS, MS, etc. also often recover after amalgam replacement(11,12,200).

A large epidemiological study of 35,000 Americans by the National Institute of Health, the nation's principal health statistics agency, found that there was a significant correlation between having a greater than average number of dental amalgam surfaces and having the a chronic condition such as epilepsy, MS, or migraine headaches. Fewer of those with this condition have zero fillings than those of the general population while significantly more of those with the condition have 17 or more surfaces than in the general population (155)

There are extensive documented cases (many thousands) where removal of amalgam fillings led to cure of serious health problems such as

eczema (22,33,34,38,52-54,67-69,11,12), psoriasis(33-38,12), asthma(49-52,68,72,98), lupus(12,27,32,33,68,70,71,31), allergies(31,32,43,48,51,49,52,53,66-74), oral lichen planus(39-42), chronic multiple chemical sensitivities (32,68,70,71,73,75-77,154, 11,12,31), ALS(51,99,154,31), arthritis(31,52,67,68,72,73,78,79,98,11), MS(52,67-70,73,80-83,31c,99,100,151-154), CFS (11,12,31,33,52-54,66-68,70,71,75,84,85,98,99,153,154)

muscular/joint pain/fibromyalgia (11,12,31,53,68,69,72,84,85,98,99,151) and over 20 other chronic health conditions(200). Any references not found in this paper can be found in the bigger paper(200), from which much of this paper is excerpted and which contains clinical documentation of over 60,000 cases of recoveries after amalgam replacement. In several of the studies, over 75% of those with MS and having amalgams replaced recovered or had significant improvement ( 212(a),(b),(e),302,222,*31). Some of the studies reported similar success rates for SLE but with lower number of cases treated.

Clinical studies have found that patch testing is not a good predictor of success of amalgam removal, as a high percentage of those testing negative also recovered from chronic conditions after replacement of fillings (86,87,90). Follow up tests for autoimmune reaction to inorganic mercury after amalgam replacement have found that in most patients tested, the immune reaction as well as most symptoms disappear over time (11,313,12b,etc.)

References

(1) American Academy of Dermatology, Press Release, February, 2000; &(b) National Institute of Arthritis and Musculoskeletal and Skin Diseases, (U.S.) National Institute of Health, 2003; & (c) CDC. Behavioral Risk Factor Surveillance System Survey. Atlanta, Georgia: U.S. Department of Health and Human Services, CDC, 2001; &(d) American Academy of Allergy, Asthma and Immunology (AAAAI). The Allergy Report: Science Based Findings on the Diagnosis & Treatment of Allergic Disorders, 1996-2001; & (e) S. Redd, U.S. Centers for Disease Control, National Center for Environmental Health, 1998.

(2)Gary Null, Second Opinion: Vaccinations, Gary Null and Associates,Inc., 2000. www.garynull.com.

(3) Silhan P, Arenberger P. Standard epicutaneous tests in ambulatory care of patients.

Cas Lek Cesk 1999, 138(15):469-73; & Lindemayr H, Drobil M. Eczema of the lower leg and contact allergy. [German] Hautarzt, 1985, 36(4): 227-3.

(4) Reichrtova E et al, “Cord Serum Immunoglobulin E Related to Environmental Contamination of Human Placentas with Oganochlorine Compounds”, Envir Health Perspec, 1999, 107(11):895-99; & Gavett SH et al. Residual Oil Fly Ash Amplifies Allergic Cytokines, Airway Responsiveness, and Inflamtion in Mice. Am J Respir Crit Care Med, 1999, 160(6):1897-1904; & Kramer U et al, Traffic-related air pollution is associated with atopy in children living in urban areas. Epidemiology 2000, 11(1): 64-70; & S.C. Langley-Evans et al, “SO2: a potent glutathione depleting agent”, Comp Biochem Physiol Pharmocol Toxicol Endocrinol, 114(2):89-98

(5) Romaguera C, Vilaplana J. Contact dermatitis in children: 6 years experience. Contact Dermatitis 1998; 39(6): 277-80; & Manzini BM, Ferdani G, Simonetti V, Donini M, Sedernari S. Contact sensitization in children. Pediatr Dermatol 1998; 15(1): 12-17.

(6) Brasch J, Geier J, Schnuch A. Differentiated contact allergy lists serve in quality improvement. Hautarzt 1998; 49(3): 184-91; & Audicana MT, Munoz D, del Pozo MD, Fernandez E, Gastaminza G, Fernandez de Corres L. Allergic contact dermatitis from mercury antiseptics and derivatives: study protocol of tolerance to intramuscular injections of thimerosal. Am J Contact Dermat. 2002 Mar;13(1):3-9.; & Patrizi A, Rizzoli L, Vincenzi C, Trevisi P, Tosti A. Sensitization to thimerosal in atopic children. Contact Dermatitis, 1999, 40(2): 94-7.

(7) Nakada T, Higo N, Iijima M, Nakayama H, Maibach HI. Contact Dermatitis. 1997 May;36(5):237-9.;

(8) Sun CC. Allergic contact dermatitis of the face from contact with nickel and ammoniated mercury. Contact Dermatitis 1987, 17(5):306-9;. & Schafer T, Bohler E, et al, Epidemiology of contact allergy in adults. Allergy. 2001 Dec;56(12):1192-6.

(9) Xue C, He Z, Zhang H, Li S. Study on the contact allergen in patients with dermatitis and eczema. Wei Sheng Yen Chiu 1997, 26(5): 296-8; & Meding B, Jarvholm B. Hand eczema in Swedish adults and children - J Invest Dermatol 2002 Apr;118(4):719-23; & Lindemayr H, Drobil M, .[Eczema of the lower leg and contact allergy] [German] Hautarzt. 1985 36(4): 227-31.

(10) Aberer W, Holub H, Strohal R, Slavicek R. Palladium in dental alloys- the dermatologists responsibility to warn? Contact Dermatitis 1993. 28(3): 163-5; & Veien NK. Stomatitis and systemic dermatitis from mercury in amalgam dental restorations.Dermatol Clin. 1990 Jan;8(1):157-60.

(11)V.D.M.Stejskal, Dept. Of Clinical Chemistry, Karolinska Institute, Stockholm, Sweden, LYMPHOCYTE IMMUNO‑STIMULATION ASSAY ‑MELISA” & VDM Stejskal et al, "MELISA: tool for the study of metal allergy", Toxicology in Vitro, 8(5):991-1000, 1994; & V.D.M.Stejskal et al, “Mercury-specific Lymphocytes: an indication of mercury allergy in man”, J. Of Clinical Immunology, 1996, Vol 16(1);31-40. www.melisa.org

& (b) Alanko K, Kanerva L, Jolanki R, Kannas L, Estlander T. Oral mucosal diseases investigated by patch testing with a dental screening series. Contact Dermatitis. 1996 Apr;34(4):263-7.

(12) Stejskal VDM, Danersund A, Lindvall A, Hudecek R, Nordman V, Yaqob A et al. Metal- specific memory lymphocytes: biomarkers of sensitivity in man. Neuroendocrinology Letters, 1999; & (b)Jenny Stejskal, Vera Stejskal. The role of metals in autoimmune diseases and the link to neuroendocrinology Neuroendocrinology Letters, 20:345‑358, 1999. &(c) Sterzl I, Prochazkova J, Stejaskal VDM et al, Mercury and nickel allergy: risk factors in fatigue and autoimmunity. Neuroendocrinology Letters 1999; 20:221-228; &(d) Sterzl I, Hrda P, Prochazkova J, Bartova J, Reactions to metals in patients with chronic fatigue and autoimmune endocrinopathy. Vnitr Lek 1999 Sep;45(9):527‑31; www.melisa.org; & (e)Valentine-Thon E, Schiwara HW, Validity of MELISA for metal sensitivity testing; Neuroendocrinol Lett, 2003, Feb-Apr, 24(1-2): 57-64.

(13) S.Ellermann-Eriksen et al, "Effect of mercuric chloride on macrophage-mediated resistance mechinisms against infection", Toxicology, 93:269-297,1994; & M.Kubicka-Muranyi et al, “Systemic autoimmune disease induced by mercuric chloride”, Int Arch Allergy Immunol;1996, 109(1):11-20 & M.M.Christensen et al, Institute o Medical Microbiology, “Comparision of interaction of meHgCl2 and HgCl2 with murine macrophages”, Arch Toxicol, 1993, 67(3):205-11; & M.Goldman et al,1991,“Chemically induced autoimmunity ...”,Immunology Today,12:223-; & K. Warfyinge et al, “Systemic autoimmunity due to mercury vapor exposure in genetically susceptible mice”, Toxicol Appl Pharmacol, 1995, 132(2):299-309;

(14)P.W. Mathieson, “Mercury: god of TH2 cells”,1995, Cliical Exp Immunol.,102(2):229-30; & Parronchi P, Brugnolo F, Sampognaro S, Maggi E. Genetic and Environmental Factors Contributing to the Onset of Allergic Disorders. Int Arch Allergy Immunol 2000 Jan;121(1):2-9.

(15) L.M. Bagentose et al, “Mercury induced autoimmunity in humans”, Immunol Res, 1999,20(1): 67-78; &“Mercury-induced autoimmunity”, Clin Exp Immunol, 1998, 114(1):9-12; B.J. Shenker et al, Dept. Of Pathology,Univ. Of Penn. School of Dental Med.,”Immunotoxic effects of mercuric compounds on human lymphocytes and monocytes:Alterations in cell viability” and “Immune suppression of human T-cell activation”, Immunopharmacologicol Immunotoxical, 1992, 14(3):555-77; &“Mercury-induced autoimmunity”, Clin Exp Immunol, 1998, 114(1):9-12.

(16) Windham, B. Annotated Bibliography: The mercury connection to childhood neurolgical and developmental conditions, http://www.flcv.com/kidshg.html

(17) Sato K, Kusaka Y, Miyakoshi S. An epideomological study of factors relating to mercury sensitization.

Arerugi 1995; 44(2):86-92; & Chen L, Nordlind K, Liden S, Sticherling M., Increased expression of keratinocyte interleukin-8 in human contact eczematous reactions to heavy metals. APMIS. 1996 Jul-Aug;104(7-8):509-14.

(18) Galindo PA, Feo F, Fernadez F. Mercurochrome allergy: immediate and delayed hypersensity. Allergy 1997; 52(11): 1138-41;

(19) Koizumi A et al, Mercury poisoning as cause of smelter disease. Lancet 1994; 343(8910): 1411-2.

(20) Ulukapi I. Mercury hypersensitivity from amalgam: report of case. ASDC J Dent Child 1995;62(5):363-4.

(21) Halsey, NA. Limiting Infant Exposure to Thimerosal in vaccines. J. of the Amer. Medical Assoc., 282: 1763-66.

(22) Redhe O, Pleva J. Recovery from asthma and allergies after removal of dental amalgam fillings. Int J of Risk & Safety in Medicine 1994; 4:229-236.

(23) Autism: a unique form of mercury poisoning. http://www.autismwebsite.com/ari/vaccine/mercurylong.htm ; & (b) Elferink JG. Thimerosal: a versatile sulfhydryl reagent, calcium mobilizer, and cell function‑modulating agent. Gen Pharmacol 1999 Jul;33(1):1‑6; & Forstrom L, Hannuksela M, Kousa M, Lehmuskallio E. Merthiolate hypersensitivity and vaccination. Contact Dermatitis. 1980 Jun;6(4):241-5; & Schafer T, Bohler E, et al, Epidemiology of contact allergy in adults. Allergy. 2001 Dec;56(12):1192-6.

(24) J.R. Cade et al, Autism and schizophrenia linked to malfunctioning enzyme for milk protein digestion. Autism, Mar 1999. http://www.hsc.ufl.edu/post/post0399/post03_19/1.html

(25) Puschel G, Mentlein R, Heymann E, 'Isolation and characterization of dipeptidyl peptidase IV from human placenta', Eur J Biochem 1982 Aug;126(2):359-65; & Shibuya-Saruta H, Kasahara Y, Hashimoto Y. Human serum dipeptidyl peptidase IV (DPPIV) and its unique properties. J Clin Lab Anal. 1996;10(6):435-40; & Blais A, Morvan-Baleynaud J, Friedlander G, Le Grimellec C. Primary culture of rabbit proximal tubules as a cellular model to study nephrotoxicity of xenobiotics. Kidney Int. 1993 Jul;44(1):13-8

(26) Stefanovic V. et al, Kidney ectopeptidases in mercuric chloride-induced renal failure. Cell Physiol Biochem 1998; 8(5): 278-84.

(27) T.A.Glavinskiaia et al, “Complexons in the treatment of lupus erghematousus”, Dermatol Venerol, 1980, 12: 24-28; & A.F.Hall, Arch Dermatol 47, 1943, 610-611.

(28) P.E. Bigazzi, “Autoimmunity and Heavy Metals”, Lupus, 1994; 3: 449-453; & (b)Pollard KM, Pearson Dl,

Hultman P. Lupus-prone mice as model to study xenobiotic-induced autoimmunity. Envriron Health

Perspect 1999; 107(Suppl 5): 729-735; & Nielsen JB; Hultman P. Experimental studies on

genetically determined susceptibility to mercury‑induced autoimmune response. Ren Fail 1999

May‑Jul;21(3‑4):343‑8; & Hultman P, Enestrom S, Mercury induced antinuclear antibodies in mice,

Clinical and Exper Immunology, 1988, 71(2): 269-274; & (d) Via CS, Nguyen P, Silbergeld EK, et

al, Low-dose exposure to inorganic mercury accelerates disease and mortality in acquired murine

lupus, Environ Health Perspect. 2003, 111(10): 1273-7; &(e) Silbergeld EK, Silva IA, Nyland JF. Mercury and autoimmunity: implications for occupational and environmental health. Toxicol Appl Pharmacol. 2005 Sep 1;207(2 Suppl):282-92.

(29) C.Gordon et al, “Abnormal sulphur oxidation in systemic lupus erythrmatosus(SLE)”, Lancet, 1992,339:8784,25-6; & P.Emory et al, “Poor sulphoxidation in patients with rheumatoid arthitis”, Ann Rheum Dis, 1992, 51:3,318-20; & P.Emory et al, Br J Rheumotol, 1992, 31:7,449-51; & C.M. Tanner et al,“Abnormal Liver Enzyme Metablolism in Parkinson’s”,Neurology, 1991, 41(5): Suppl 2, 89-92; & Wilkinson LJ, Waring RH. Cysteine dioxygenase: modulation of expression in human cell lines by cytokines and control of sulphate production. Toxicol In Vitro. 2002 Aug;16(4):481-3; & Hisatome I, et al, Block of sodium channels by divalent mercury: role of specific cysteinyl residues in the P-loop region. Biophys J. 2000 Sep;79(3):1336-45.

(30)S.A. McFadden, “Xenobiotic metabolism and adverse environmental response: sulfur-dependent detox pathways”,Toxicology, 1996, 111(1-3):43-65; ;& (b) Markovich et al, "Heavy metals (Hg,Cd) inhibit the activity of the liver and kidney sulfate transporter Sat‑1", Toxicol Appl Pharmacol, 1999,154(2):181‑7;&(c)Alberti A, Pirrone P, Elia M, Waring RH, Romano C. Sulphation deficit in “low-functioning” autistic children. Biol Psychiatry 1999, 46(3):420-4; &(d) Quig D, Doctors Data Lab,"Cysteine metabolism and metal toxicity", Altern Med Rev, 1998;3:4, p262‑270, &(e) J.de Ceaurriz et al, Role of gamma‑ glutamyltraspeptidase(GGC) and extracellular glutathione in dissipation of inorganic mercury",J Appl Toxicol,1994, 14(3): 201‑;

(31 Huggins HA, Levy,TE, Uniformed Consent: the hidden dangers in dental care, 1999, Hampton Roads Publishing Company Inc; & (b)Hal Huggins, Its All in Your Head, 1993; & (c) Huggins HA, Levy,TE, Solving the MS Mystery: Help, hope and recovery, 2002 & Center for Progressive Medicine, 1999, http://www.hugnet.com